Related references
Note: Only part of the references are listed.Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome
Sarah Deschuymer et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685
Val J. Lowe et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus?Associated Oropharyngeal Squamous Cell Carcinoma
Bhishamjit S. Chera et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
T. Y. Seiwert et al.
ANNALS OF ONCOLOGY (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
Patrick D. Maguire et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
The risk of carotid stenosis in head and neck cancer patients after radiation therapy
David J. Carpenter et al.
ORAL ONCOLOGY (2018)
Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later
Shao Hui Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline
David J. Sher et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer
V. M. Villaflor et al.
ANNALS OF ONCOLOGY (2016)
Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma
Sven van den Bosch et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes
A. B. Miah et al.
BRITISH JOURNAL OF CANCER (2015)
Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)-Interreader Reliability, Accuracy, and Survival Outcomes
Charles Marcus et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: Implications for CTV margin, elective nodal dose and bilateral parotid sparing
Virag Dandekar et al.
ORAL ONCOLOGY (2014)
Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer With Intensity Modulated Radiation Therapy
Adam S. Garden et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy
D. J. Sher et al.
ANNALS OF ONCOLOGY (2012)
REGIONAL RELAPSE AFTER INTENSITY-MODULATED RADIOTHERAPY FOR HEAD-AND-NECK CANCER
Frederic Duprez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Selective neck dissection for N0 and N1 oral cavity and oropharyngeal cancer: are skip metastases a real danger?
W. L. Lodder et al.
CLINICAL OTOLARYNGOLOGY (2008)
Distributions of cervical lymph node metastases in oropharyngeal carcinoma: Therapeutic implications for the N0 neck
Young Chang Lim et al.
LARYNGOSCOPE (2006)
Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically NO laryngeal carcinoma?
YC Lim et al.
ORAL ONCOLOGY (2006)
Share Paper
